Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-12-07
1996-06-18
Morris, Patricia L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5482664, A61K 3141, C07D40306
Patent
active
055278175
ABSTRACT:
The sulphate salt of N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine is a selective agonist of 5-HT.sub.1 -like receptors and is therefore useful in the treatment of clinical conditions, in particular migraine and associated disorders, for which a selective agonist of these receptors is indicated.
REFERENCES:
patent: 5298520 (1994-03-01), Baker et al.
G. R. Martin et al., "Analysis of the 5-HT receptor, etc" 342, 8, 111 (1990).
Baker Raymond
Guiblin Alexander R.
Matassa Victor G.
Olive Carole
Pitt Kendal G.
Merck Sharp & Dohme Limited
Morris Patricia L.
North Robert J.
Winokur Melvin
LandOfFree
Sulphate salt of a substituted triazole, pharmaceutical composit does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulphate salt of a substituted triazole, pharmaceutical composit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulphate salt of a substituted triazole, pharmaceutical composit will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-223212